Looking at the AI Renaissance in Medtech

When I joined MD+DI nearly a year ago, I would hear smatterings about artificial intelligence and machine learning in medtech. But then something happened. By mid-February every other pitch I started receiving was AI-related. Conferences started delving into the AI topic. I even participated in a webinar hosted by Dave Saunders, CTO and Co-founder of Galen Robotics. It was clear to me that AI wasn’t just a buzzword, or some fancy marketing scribble used to catch a journalist’s attention. AI is something more than a trend. It’s going to be interwoven into the very fabric of medtech. These sometimes software-like solutions will only serve to enhance established and sometimes new devices. But how? Is this just pie in the sky that I’m talking about or is there some sort of tangible example? Let’s look at the case of Beta Bionics. Back in May, I had the pleasure of interviewing the CEO of the startup and learning about the bionic pancreas, called the iLet. The device consists of a dual-chamber, autonomous, infusion pump that mimics a biological pancreas. The body-worn device contains a little cartridge with insulin in it. The device is connected to the body through a tube with insulin. There is also a two-hormone version of the technology, so it can be configured to use insulin or glucagon. Here’s where the AI component comes in. Embedded in the system are clinically tested ...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news